Lindbrook Capital’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
AIM
Lindbrook Capital's PTEN Position: Q1 2025 in Review
Lindbrook Capital reduced its Patterson-UTI (PTEN) stake by 2.5% in Q1 2025, selling an estimated $780 and leaving 3,653 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.
Lindbrook Capital first reported a position in PTEN in Q4 2018 and has held it in 23 quarters since. The position peaked at $45.2K in Q3 2023. 381 funds tracked by Wall St. Rank hold PTEN as of Q1 2025.
- Lindbrook Capital held 3,653 shares of Patterson-UTI worth $30K as of Q1 2025.
- Lindbrook Capital sold 93 Patterson-UTI shares in Q1 2025, an estimated $780.
- Patterson-UTI made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1187 holding.
- Lindbrook Capital first reported a position in Patterson-UTI in Q4 2018 and has held it in 23 quarters since.
- Lindbrook Capital's Patterson-UTI position peaked at $45.2K in Q3 2023.
- 381 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.